ABZENA LIMITED
Company number 08957107 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2014-03-25
- Registered office
- Babraham Research Campus, Babraham, Cambridge, CB22 3AT
- Postcode
- CB22 3AT
- Accounts category
- Audit Exemption Subsidiary
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-03-19
- Next due by
- 2027-04-02
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 11 current · 9 resigned
Geoffrey Michael GLASS
Director
Thomas Paul CASTELLANO
Director
Michelle Dawn NEAVES
Director
PETER WILLIAM GRANT
Director
DR ANKER LUNDEMOSE
Director
Group structure 2 subsidiaries
Controlled by ASTRO BIDCO LIMITED — since 2018-10-11
-
ABZENA HOLDINGS LIMITED Dissolved
From persons-with-significant-control filings on the public register.
Contact details
- Website
- abzena.co.uk
Abzena is a fully integrated biopharmaceutical CDMO+CRO for antibodies, ADCs, AOCs, RDCs, vaccines, from discovery thru commercial.
Previous company names
| Name | Date changed |
|---|---|
| ABZENA PLC | 2018-10-22 |
| ABZENA LIMITED | 2014-07-03 |
| POLYTHERICS GROUP LIMITED | 2014-05-22 |
Previous registered addresses 1
| Address | Changed on |
|---|---|
| THE LONDON BIOSCIENCE INNOVATION CENTRE 2 ROYAL COLLEGE STREET, LONDON, NW1 0NH, UNITED KINGDOM | 2014-06-18 |
Among its peers
Among the oldest 25%
of 365 similar companies in CB, trading since 2014
The class of 2014
38%
of the 357 companies in this sector incorporated in 2014 are still active today; 59% have since been dissolved.
A fact about the year, not a forecast for this company.